4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-003807
EVP, Chief Operating Officer sold 827 shares at $18.09 ($14,960)
- EVP, Chief Operating Officer gave up 423 shares (to pay taxes)
- EVP, Chief Operating Officer acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-01-13 | Option exercise | +1,250 | 1,250 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-01-13 | Shares withheld for taxes | −423 | $18.16 | $7,682 | 827 | D |
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-01-14 | Sale | −827 | $18.09 | $14,960 | 0 | D |
| Derivatives | |||||||
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-01-13 | Option exercise · Restricted Stock Units | −1,250 | 18,750 | D | ||
| Open-market sales · 827 sh · avg $18.09 · $14,960 | |||||||
Loading xslF345X03/doc4.xml…